Growing community of inventors

Munich, Germany

Jan Endell

Average Co-Inventor Count = 3.47

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 29

Jan EndellRainer Boxhammer (8 patents)Jan EndellMark Winderlich (7 patents)Jan EndellLisa Rojkjaer (5 patents)Jan EndellChristofer Samuelsson (4 patents)Jan EndellStefan Härtle (2 patents)Jan EndellStéphane LeClair (2 patents)Jan EndellStefan Hartle (1 patent)Jan EndellKonstantin Petropoulos (1 patent)Jan EndellPeter Kelemen (1 patent)Jan EndellMarkus Rückert (1 patent)Jan EndellDominik Pretscher (0 patent)Jan EndellLisa Rojkjaer (1 patent)Jan EndellStephane Leclair (1 patent)Jan EndellJan Endell (11 patents)Rainer BoxhammerRainer Boxhammer (8 patents)Mark WinderlichMark Winderlich (7 patents)Lisa RojkjaerLisa Rojkjaer (5 patents)Christofer SamuelssonChristofer Samuelsson (4 patents)Stefan HärtleStefan Härtle (3 patents)Stéphane LeClairStéphane LeClair (2 patents)Stefan HartleStefan Hartle (2 patents)Konstantin PetropoulosKonstantin Petropoulos (4 patents)Peter KelemenPeter Kelemen (1 patent)Markus RückertMarkus Rückert (1 patent)Dominik PretscherDominik Pretscher (0 patent)Lisa RojkjaerLisa Rojkjaer (1 patent)Stephane LeclairStephane Leclair (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Morphosys Ag (9 from 88 patents)

2. Incyte Corporation (2 from 671 patents)


11 patents:

1. 12358983 - Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof

2. 12194095 - Combinations and uses thereof

3. 11591406 - Treatment for multiple myeloma (MM)

4. 11224654 - Combinations and uses thereof

5. 10617691 - Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor and uses thereof

6. 10533057 - Treatment for multiple myeloma (MM)

7. 10308722 - Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-CD38 antibody in combination with thalidomine, lenalidomids, or pomalidomide

8. 9765152 - Method for the treatment of multiple myeloma or non-Hodgkins lymphoma with anti-CD38 antibody and bortezomib or carfilzomib

9. 9579378 - Combinations and uses thereof

10. 9289490 - Combinations and uses thereof

11. 8877899 - Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multipe myeloma and NHL

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/17/2026
Loading…